Fibroid Foundation, Bethesda, MD, USA.
Department of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL, 60637, USA.
Adv Ther. 2023 Oct;40(10):4127-4133. doi: 10.1007/s12325-023-02595-x. Epub 2023 Aug 12.
Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article.
子宫肌瘤（UF）是女性常见的良性肿瘤，也是美国和全球的一个重要健康关注点。UF 会严重影响女性的生活质量，因此是一个重要的健康问题。在这个播客中，芝加哥大学妇产科教授（Ayman Al-Hendy 博士）和纤维瘤基金会首席执行官（Sateria Venable）就 UF 的诊断和管理提供了他们的观点，包括常见的治疗方法（如子宫肌瘤切除术或子宫切除术）。他们还讨论了 UF 的 Relugolix 联合疗法，指出谁可能从这种治疗中受益以及它是如何起作用的。本文提供播客音频。
